Viberzi

Chemical Nameeluxadoline
Dosage FormFor treatment of adults with irritable bowel syndrome with diarrhea (IBS-D).
Drug ClassReceptor antagonists
SystemDigestive
CompanyAllergan
Approval Year2015

Indication

  • For treatment of adults with irritable bowel syndrome with diarrhea (IBS-D).
Last updated on 9/2/2022

More on this drug: Clinical Trials

Document TitleYearSource
Viberzi (eluxadoline) Prescribing Information.2020Allergan USA, Inc., Madison, NJ

Have we missed a study, or would you like to comment on a study?